- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------

SCHEDULE 13E-3
RULE 13e-3 TRANSACTION STATEMENT
(PURSUANT TO SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934)

AMENDMENT NO. 2

SHERIDAN HEALTHCARE, INC.
(NAME OF THE ISSUER)

VESTAR/SHERIDAN, INC.
VESTAR/SHERIDAN HOLDINGS, INC.
VESTAR/SHERIDAN INVESTORS, LLC
SHERIDAN HEALTHCARE, INC.
MITCHELL EISENBERG
LEWIS D. GOLD
MICHAEL F. SCHUNDLER
GILBERT L. DROZDOW
JAY A. MARTUS
ROBERT J. COWARD
(NAME OF PERSON(S) FILING STATEMENT)

COMMON STOCK, PAR VALUE $0.01 PER SHARE
CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE
(TITLES OF CLASSES OF SECURITIES)

COMMON STOCK 823781109
CLASS A COMMON STOCK 823781208
(CUSIP NUMBER OF CLASSES OF SECURITIES)

JAMES L. ELROD, JR. MITCHELL EISENBERG, M.D.
VESTAR/SHERIDAN INVESTORS, LLC SHERIDAN HEALTHCARE, INC.
245 PARK AVENUE, 41ST FLOOR 4651 SHERIDAN STREET, SUITE 400
NEW YORK, NY 10167 HOLLYWOOD, FL 33021
(212) 351-1600 (954) 964-2611

(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED
TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF PERSON(S) FILING STATEMENT)

COPIES TO:

PETER J. GORDON, ESQ. STEPHEN K. RODDENBERRY, ESQ.
SIMPSON THACHER & BARTLETT AKERMAN, SENTERFITT, EIDSON, P.A.
425 LEXINGTON AVENUE ONE SOUTHEAST THIRD AVENUE
NEW YORK, NEW YORK 10017 28TH FLOOR
(212) 455-2000 MIAMI, FLORIDA 33131

This statement is filed in connection with (check the appropriate box):

a. [ ] The filing of solicitation materials or an information statement
subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under
the Securities Exchange Act of 1934.

b. [ ] The filing of a registration statement under the Securities Act of
1933.

c. [X] A tender offer.

d. [ ] None of the above.

Check the following box if the soliciting materials or information
statement referred to in checking box (a) are preliminary copies: [ ]

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
2

This Amendment No. 2 amends and supplements the Rule 13E-3 Transaction
Statement (as amended to date, the "Schedule 13E-3") relating to a tender offer
by Vestar/Sheridan, Inc., a Delaware corporation (formerly known as
Vestar/Calvary, Inc.) (the "Purchaser") and a wholly owned subsidiary of Vestar/
Sheridan Holdings, Inc., a Delaware corporation (formerly known as
Vestar/Calvary Holdings, Inc.) ("Holdings") and a wholly owned subsidiary of
Vestar/Sheridan Investors, LLC, a Delaware limited liability company (formerly
known as Vestar/Calvary Investors, LLC) ("Parent"), to purchase all of the
outstanding shares of Common Stock, par value $0.01 per share (the "Common
Stock"), and Class A Common Stock, par value $0.01 per share (the "Class A
Common Stock" and, together with the Common Stock, the "Shares"), of Sheridan
Healthcare, Inc., a Delaware corporation (the "Company"), at a price of $9.25
per Share net to the seller in cash and without interest thereon, on the terms
and subject to the conditions set forth in the Offer to Purchase dated March 31,
1999 (the "Offer to Purchase") and in the related Letters of Transmittal (which,
together with the Offer to Purchase, constitute the "Offer").

Capitalized terms not defined herein have the meanings assigned thereto in
the Schedule 13E-3.

The following cross reference sheet is being supplied pursuant to General
Instruction F to Schedule 13E-3 and shows the location in the Tender Offer
Statement on Schedule 14D-1 (the "Schedule 14D-1") filed by the Purchaser with
the Securities and Exchange Commission on the date hereof of the information
required to be included in response to the items of this Statement. The
information in the Schedule 14D-1 is hereby expressly incorporated herein by
reference.

CROSS-REFERENCE SHEET

ITEM IN SCHEDULE 13E-3 WHERE LOCATED IN SCHEDULE 14D-1
---------------------- -------------------------------

Item 17(c) Item 11(c)

- ---------------

ITEM 17. MATERIAL TO BE FILED AS EXHIBITS.

Item 17 of the Rule 13E-3 Transaction Statement is hereby amended and
supplemented as follows:

(c)(13) Guaranty Agreement, dated as of March 24, 1999, between Vestar Capital
Partners III, L.P. and the Company.

i
3

SIGNATURES

After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

VESTAR/SHERIDAN INVESTORS, LLC

By: VESTAR CAPITAL PARTNERS III,
L.P.,
------------------------------------
its Sole Member

By: VESTAR ASSOCIATES III,
L.P.,
------------------------------------
its General Partner

By: VESTAR ASSOCIATES CORPORATION
III
------------------------------------
its General Partner

By: JAMES L. ELROD, JR.

------------------------------------
Name: James L. Elrod, Jr.
Title: Vice President

VESTAR/SHERIDAN HOLDINGS, INC.

By: JAMES L. ELROD, JR.

------------------------------------
Name: James L. Elrod, Jr.
Title: President

VESTAR/SHERIDAN, INC.

By: JAMES L. ELROD, JR.

------------------------------------
Name: James L. Elrod, Jr.
Title: President

SHERIDAN HEALTHCARE, INC.

By: JAY A. MARTUS

------------------------------------
Name: Jay A. Martus
Title: Vice President and General
Counsel

MITCHELL EISENBERG

--------------------------------------
Mitchell Eisenberg

ii
4

LEWIS D. GOLD

--------------------------------------
Lewis D. Gold

MICHAEL F. SCHUNDLER

--------------------------------------
Michael F. Schundler

GILBERT L. DROZDOW

--------------------------------------
Gilbert L. Drozdow

JAY A. MARTUS

--------------------------------------
Jay A. Martus

ROBERT J. COWARD

--------------------------------------
Robert J. Coward

April 6, 1999

iii
5

EXHIBIT INDEX

(c)(13) Guaranty Agreement, dated as of March 24, 1999, between
Vestar Capital Partners III, L.P. and the Company.